Breaking into our toolbox this week! Dr. Moise takes us through immune therapy options in the treatment and management of HDFN and alloimmunization.

This week we cover the following topics:

• Alloimmunized patients that qualify for immune therapy as management for HDFN
• Options available for immune therapy
  • Intravenous immunoglobulin (IVIG)
  • Plasmapheresis
• Timing, dosing, frequency, and administration of IVIG
• Common complications of IVIG
  • IgA deficiency
  • Headache
  • Fatigue
  • FDA Black Box Warning
• And our tricks for treating them!
  • Imitrex (sumatriptan) + Zofran (ondansetron)
  • Reglan (metoclopramide)
  • IVIG pre-meds and post-meds
  • IVIG rate adjustment